PepGen Inc.
Status: Publicly traded
Direct answer
PepGen Inc. is publicly traded on NASDAQ under the ticker PEPG.
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic...
Can you invest in PepGen Inc.?
Yes. PepGen Inc. is publicly traded on NASDAQ under the ticker PEPG.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Detailed equity research is provided by MarketSnap.